Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension.

Ziran WangJintu ChenJingjing SongLingjun KongXuanzhi WangTeng-Da XuSongbai LinYaling Dou

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)

4G/5G polymorphism may not be associated with genetic susceptibility to DM, HTN and DM+HTN, but differences in clinical characteristics among individuals with various genotypes may provide a reference for disease assessment and personalized treatment of patients.

Keyphrases

glycemic control
blood pressure
genome wide
copy number
dna methylation
skeletal muscle
metabolic syndrome
adipose tissue
gene expression
weight loss
clinical evaluation
arterial hypertension